You are here

Prime Medicine

Prime editing comes of age as FDA clears human trials

Pharmaphorum

Tue, 04/30/24 - 08:28 am

clinical trials

Gene-editing firm Prime Medicine files $140m public offer

Pharmaphorum

Thu, 02/15/24 - 11:17 am

Prime and Cimeio form research alliance to develop genetic disease solution

Medical Device Network

Fri, 06/23/23 - 09:40 am

Cimeio Therapeutics

genetic diseases

A stealth biotech startup is quietly advancing a new drugmaking tool from David Liu’s lab

BioPharma Dive

Wed, 04/5/23 - 07:22 pm

Beam Therapeutics

Resonance Medicine

JPM23: Takeda tests Bristol Myers, Prime weighs spinoffs and Sanofi faces down a competitor

BioPharma Dive

Wed, 01/11/23 - 11:08 pm

Bristol Myers Squibb

IPOs fail to bounce back in Q4

EP Vantage

Thu, 01/5/23 - 10:16 am

Acrivon Therapeutics

Lipella Pharmaceuticals

Prime time for IPO as gene editing biotech goes public with $175M

Fierce Biotech

Thu, 10/20/22 - 11:26 pm

Prime Medicine becomes the next high-profile biotech to test the IPO waters

BioPharma Dive

Mon, 09/26/22 - 11:33 pm

2 gene editing biotechs team up to improve on delivery with $45 upfront

Fierce Biotech

Thu, 03/31/22 - 11:20 pm

Myeloid Therapeutics